5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors
5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeico...
Saved in:
Published in | The Journal of experimental medicine Vol. 183; no. 4; pp. 1633 - 1643 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Rockefeller University Press
01.04.1996
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-1007 1540-9538 |
DOI | 10.1084/jem.183.4.1633 |
Cover
Abstract | 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells. |
---|---|
AbstractList | 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells.5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells. 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S), 15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-diHETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE, PMN from asthmatics were able to produce 5(S), 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells. 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce lipoxins (LXs), leukotrienes, and 5(S),15(S)-dihydroxyeicosatetraenoic acid [5(S),15(S)-diHETE] were compared under in vitro stimulation by ionophore A23187, with or without exogenous 15(S)-hydroxyeicosatetraenoic acid [15(S)-HETE]. Eicosanoids were analyzed by elution with an isocratic reverse-phase high performance liquid chromatography system, and their profiles, detected by simultaneous monitoring at 302, 280, and 246 nm, were evaluated on the basis of chromatographic behavior: UV spectral characteristics and coelution with synthetic standards. In the presence of exogenous 15(S)-HETE, human PMN were able to produce LXs and 5(S),15(S)-diHETE. Moreover, the total amount of LXs biosynthesized by PMN from asthmatics was twofold higher than that biosynthesized by PMN from controls. In the absence of exogenous 15(S)-HETE, PMN from asthmatics were able to produce 5(S),15(S)-diHETE, and LXs from endogenous sources, whereas in the same experimental conditions, no detectable amounts of these compounds were released by PMN from controls. The levels of 5(S),15(S)-diHETE, and LXs biosynthesized from endogenous arachidonic acid were highly correlated. Two different LX patterns were observed involving two possible metabolic pathways: (a) via the intermediate 5,6-epoxytetraene alone for LXs generation from exogenous 15(S)-HETE; and (b) via 5,6- and/or 14,15-epoxytetraenes leading to the formation of an enzyme-bound delocalized carbocation for LXs generation from endogenous arachidonate, respectively. The enhanced 5-lipoxygenase activation of blood PMN from asthmatics and the metabolism of exogenous 15(S)-HETE may reflect a priming induced by various mediators released from environmental cells, and could be considered as a model of transcellular signalization between PMN and endothelial cells. |
Author | Vachier, I Chanez, P Godard, P Chavis, C Bousquet, J |
Author_xml | – sequence: 1 givenname: C surname: Chavis fullname: Chavis, C – sequence: 2 givenname: I surname: Vachier fullname: Vachier, I – sequence: 3 givenname: P surname: Chanez fullname: Chanez, P – sequence: 4 givenname: J surname: Bousquet fullname: Bousquet, J – sequence: 5 givenname: P surname: Godard fullname: Godard, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8666921$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQtVBR2Rau3JB8QiCRYDuJ1-4BCVV8SZU4AGfLsSddV4kd7AQ2P4t_iLNdKkBCXGyN583zzLx3hk588IDQY0pKSkT98gaGkoqqrEvKq-oe2tCmJoVsKnGCNoQwVlBCtg_QWUo3hNC6bvgpOhWcc8noBv1onn16_oKuZ2HdbrEx7BdwJiQ9wRQ1-OAM1sZZrL3FvRvD3nl8DR6inlzwOEe7edAej6FfhhDHXfCz6UFHbKDv0wW2s-5xGsG4zhk3LTh0uCkOVEsm0gnwFL7raBMGb0N-CnM6fAf7X9EYwcwxhZgeovud7hM8Ot7n6MvbN58v3xdXH999uHx9VZhasKnQTLSmbrdNBwK4oTYHvOsE2FaCraqKNBVhXLbdtpVNbTKQtQyYNEZYyVl1jl7d8o5zO4A14PM6ejVGN-i4qKCd-jPj3U5dh2-KUckaSjLB0yNBDF9nSJMaXFpXoj3kkdRWUCKJkP8F0oZzIcXK-OT3lu56OaqZ8-Vt3sSQUoTuDkGJWt2isltUdouq1eqWXFD_VZD1OciaJ3L9v8p-AnIByq8 |
CitedBy_id | crossref_primary_10_1096_fj_00_0508hyp crossref_primary_10_1007_s11745_005_1379_z crossref_primary_10_1152_ajplung_00018_2008 crossref_primary_10_1152_ajprenal_00224_2003 crossref_primary_10_1016_j_mam_2017_04_006 crossref_primary_10_1016_S0022_3565_24_37857_7 crossref_primary_10_1038_s41419_020_02846_7 crossref_primary_10_1007_s00109_017_1542_4 crossref_primary_10_1016_j_bbalip_2021_159093 crossref_primary_10_1016_j_jaci_2012_07_048 crossref_primary_10_3389_froh_2023_1288722 crossref_primary_10_3389_fphar_2022_838782 crossref_primary_10_1067_mai_2001_113868 crossref_primary_10_1021_bi992551b crossref_primary_10_1164_rccm_200201_053OC crossref_primary_10_1016_j_rmr_2011_12_009 crossref_primary_10_5936_csbj_201303018 crossref_primary_10_3389_fimmu_2022_915261 crossref_primary_10_1016_S0090_6980_97_00001_4 crossref_primary_10_4049_jimmunol_170_12_6266 crossref_primary_10_1111_all_15103 crossref_primary_10_1074_jbc_272_11_6972 crossref_primary_10_1517_14712598_2016_1118458 crossref_primary_10_1183_09031936_00106013 crossref_primary_10_1016_S0006_2952_98_00086_0 crossref_primary_10_1096_fsb2fj000508hyp crossref_primary_10_1016_S0090_6980_02_00047_3 crossref_primary_10_1021_acs_biochem_5b01339 crossref_primary_10_1073_pnas_96_14_8247 crossref_primary_10_1006_bbrc_2001_6155 crossref_primary_10_1084_jem_189_12_1923 crossref_primary_10_1096_fj_01_0576fje crossref_primary_10_1096_fj_15_275487 crossref_primary_10_1515_CCLM_1999_052 crossref_primary_10_1021_acs_biochem_0c00622 crossref_primary_10_4049_jimmunol_169_12_7063 crossref_primary_10_1016_j_bbalip_2020_158702 crossref_primary_10_1186_s13052_024_01654_5 crossref_primary_10_4049_jimmunol_1500610 crossref_primary_10_1016_j_plefa_2005_05_017 crossref_primary_10_1006_abio_1999_4113 crossref_primary_10_1074_jbc_M210294200 crossref_primary_10_1371_journal_pone_0112816 crossref_primary_10_1016_j_prostaglandins_2023_106726 crossref_primary_10_1155_2015_781087 crossref_primary_10_1096_fasebj_12_6_487 crossref_primary_10_3389_fimmu_2020_01307 crossref_primary_10_1111_j_1398_9995_2004_00617_x crossref_primary_10_1074_jbc_273_49_32535 crossref_primary_10_1089_wound_2014_0589 crossref_primary_10_1016_j_bcp_2007_04_005 crossref_primary_10_1016_j_jaci_2012_01_073 crossref_primary_10_1016_j_bbalip_2018_10_003 crossref_primary_10_1016_j_plefa_2005_05_002 crossref_primary_10_1038_89759 crossref_primary_10_1067_mai_2000_105122 crossref_primary_10_1177_154405910308200202 crossref_primary_10_1016_j_biopha_2007_02_016 crossref_primary_10_3390_cancers6031500 crossref_primary_10_1016_j_prostaglandins_2021_106610 crossref_primary_10_1016_j_tetlet_2010_01_109 crossref_primary_10_1177_154411130301400102 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 5PM |
DOI | 10.1084/jem.183.4.1633 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1540-9538 |
EndPage | 1643 |
ExternalDocumentID | PMC2192510 8666921 10_1084_jem_183_4_1633 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ 0VX 18M 29K 2WC 36B 3O- 53G 5GY 5RE 5VS 9M8 AAYXX ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFFNX AFOSN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CITATION CS3 D-I DIK DU5 E3Z EBS EMB F5P F9R GX1 H13 HYE H~9 IH2 K-O KQ8 L7B MVM N9A O5R O5S OK1 P2P P6G R.V RHI SJN TR2 TRP UHB VH1 W8F WOQ X7M ZGI CGR CUY CVF ECM EIF FRP NPM RHF RPM VXZ 7T5 H94 7X8 5PM |
ID | FETCH-LOGICAL-c482t-a28bc4b75fe8e6c1dc4b6ff8edb9ed3330530269bf7b954c75f2b2e29cc8d9623 |
ISSN | 0022-1007 |
IngestDate | Thu Aug 21 18:10:16 EDT 2025 Fri Sep 05 04:48:10 EDT 2025 Thu Sep 04 19:38:42 EDT 2025 Wed Feb 19 02:36:43 EST 2025 Tue Jul 01 03:29:44 EDT 2025 Thu Apr 24 22:52:18 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c482t-a28bc4b75fe8e6c1dc4b6ff8edb9ed3330530269bf7b954c75f2b2e29cc8d9623 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC2192510 |
PMID | 8666921 |
PQID | 15668980 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2192510 proquest_miscellaneous_78109089 proquest_miscellaneous_15668980 pubmed_primary_8666921 crossref_primary_10_1084_jem_183_4_1633 crossref_citationtrail_10_1084_jem_183_4_1633 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1996-04-01 |
PublicationDateYYYYMMDD | 1996-04-01 |
PublicationDate_xml | – month: 04 year: 1996 text: 1996-04-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of experimental medicine |
PublicationTitleAlternate | J Exp Med |
PublicationYear | 1996 |
Publisher | The Rockefeller University Press |
Publisher_xml | – name: The Rockefeller University Press |
SSID | ssj0014456 |
Score | 1.769222 |
Snippet | 5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1633 |
SubjectTerms | Arachidonate 5-Lipoxygenase - metabolism Arachidonic Acids - biosynthesis Asthma - metabolism Calcimycin - pharmacology Chromatography, High Pressure Liquid Female Humans Hydroxyeicosatetraenoic Acids - biosynthesis Hydroxyeicosatetraenoic Acids - metabolism Hydroxyeicosatetraenoic Acids - pharmacology Male Models, Biological Neutrophil Activation - drug effects Neutrophil Activation - physiology Substrate Specificity |
Title | 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8666921 https://www.proquest.com/docview/15668980 https://www.proquest.com/docview/78109089 https://pubmed.ncbi.nlm.nih.gov/PMC2192510 |
Volume | 183 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEGgvE7eJcvUDEqCSLnGcxOENTaANNF62ob1FceyqRW1StZ207l_xzo_jHMe5dasEvERx4tppvi_2sf2dY0LeCAHdsAoDh6eKOVxo6UiZeo7HNJNumI60EWOefA-PzvnXi-Ci1_vdUi1druQwu77Vr-R_UIVrgCt6yf4DsnWhcAHOAV84AsJw_CuMAzAPT2EsD-_Jq84dNRmvFYpTNIC8BFNytUh1XmBc1mxiArMOppN5cTXJcftkbRkAqXK7vnkxXc-KBUrWMdRxuhjg3L4Rzhm3LXTNRHmRlXIEjilsDUVBfwiWLKpwlwOdq8KGf8UK9VWVmi9wgn9Z2EWknw1ZW6ZxZ9uBzdX_w3EdGKG69AMVoSX3jlvZcjs7Xk85wANAN9haDVPW_y9sqWQa9wOUdnSbcL_FVd5qkMHc9G_tKVzBsafQsyH8eMiHmxnhtc5nhjcCRnhx6ca9EZrb3rlD7rIoKkUCx9_qNSzOzd7B9QNXIUMFP-hWu0vu2ZK6xtGNEc-mcLdlCZ09IHsWJ_qp5OND0tP5I3L_xML0mPwK3p2-_-DhcTsZKZKRAjeoJSNtyEghZchIb5CRGjJ-pEhF2qIiLUa0S0VqqUgbKprqairShopPyPmXz2eHR47dGcTJuGArJ2VCZlxGATQlOsw8BYlwNBJayVgr34dOzHdZGMtRJOOAZ5CRSWh94iwTKgaLf5_s5EWunxLq6YhpP41ZxCTPAjBfAyhXZVIFzPV12idOBUmS2bD5uHvLNDHyDcETADMBMBOeIJh98rbOPy8DxmzN-bpCOIE2Hd8ffBjw_xOcUxGxcLfniAQKqkXcJ_slI-q6LJP6JOpQpb6P4eS7d_LJ2ISVB9sFBjvus21FPie7zQf5guysFpf6JVjkK_nKEP8PM4_qfA |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5%28S%29%2C15%28S%29-dihydroxyeicosatetraenoic+acid+and+lipoxin+generation+in+human+polymorphonuclear+cells%3A+dual+specificity+of+5-lipoxygenase+towards+endogenous+and+exogenous+precursors&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Chavis%2C+C&rft.au=Vachier%2C+I&rft.au=Chanez%2C+P&rft.au=Bousquet%2C+J&rft.date=1996-04-01&rft.issn=0022-1007&rft.volume=183&rft.issue=4&rft.spage=1633&rft_id=info:doi/10.1084%2Fjem.183.4.1633&rft_id=info%3Apmid%2F8666921&rft.externalDocID=8666921 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |